Amitriptyline appears to relieve pain effectively in about 1 in 4 (25%) more people with fibromyalgia than does placebo. About 1 in 3 (31%) more people than with placebo report having one or more adverse events.
A Cochrane review 1 included nine studies with 649 participants. The daily dose of amitriptyline was 25 mg to 50 mg, and some studies had an initial titration period.
There was no first or second tier evidence for amitriptyline in the treatment of fibromyalgia. Using third tier evidence the RR for at least 50% pain relief, or equivalent, with amitriptyline compared with placebo was 3.0 (95% CI 1.7 to 4.9), with an NNT of 4.1 (2.9 to 6.7). There were no consistent differences between amitriptyline and placebo or other active comparators for relief of symptoms such as fatigue, poor sleep, quality of life, or tender points. More participants experienced at least one adverse event with amitriptyline (78%) than with placebo (47%). The RR was 1.5 (1.3 to 1.8) and the NNH was 3.3 (2.5 to 4.9).
Comment: The quality of evidence is downgraded by sparse data.
1. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2015, Issue 7. Art. No.: CD011824.
Copyright © 2023 Duodecim Medical Publications Limited.
Amitriptyline for fibromyalgia
is a sample topic from the Evidence-Based Medicine Guidelines
To view other topics, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Complete Product Information.
"Amitriptyline for Fibromyalgia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451250/all/Amitriptyline_for_fibromyalgia.
Amitriptyline for fibromyalgia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451250/all/Amitriptyline_for_fibromyalgia. Accessed March 22, 2023.
Amitriptyline for fibromyalgia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451250/all/Amitriptyline_for_fibromyalgia
Amitriptyline for Fibromyalgia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451250/all/Amitriptyline_for_fibromyalgia.
TY - ELEC
T1 - Amitriptyline for fibromyalgia
ID - 451250
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451250/all/Amitriptyline_for_fibromyalgia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine